Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Determination of cross-reactive immunologic material status in patients with Pompe disease
Evaluating the best strategy for enzyme replacement therapy for patients with Pompe disease
This test is used to determine cross-reactive immunological material (CRIM) status in patients with Pompe disease.
CRIM status is important when assessing whether immunosuppression is needed when initiating enzyme replacement therapy for patients with Pompe disease.
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
FIBR | Fibroblast Culture | Yes | Yes |
CRYOB | Cryopreserve for Biochem Studies | No | Yes |
When this test is ordered, a fibroblast culture and cryopreservation for biochemical studies will always be performed at an additional charge. However, for multiple lysosomal enzyme assays on a patient utilizing fibroblast culture, only one culture is required regardless of the number of enzyme assays ordered. If viable cells are not obtained within 10 days, client will be notified.
See Newborn Screen Follow-up for Pompe Disease In Special Instructions
PDCRF: Western blot
CRYOB: Fibroblast Subculture Followed by Cryopreservation and Storage